Lloyd testified that under the licensing deal, Boehringer’s manufacture of linagliptin in Germany infringed Royalty Pharma’s patent in that country, thus …
Lloyd testified that under the licensing deal, Boehringer’s manufacture of linagliptin in Germany infringed Royalty Pharma’s patent in that country, thus …